| 0 |
WRONG PRODUCT PROCURED |
6 |
0.0909 |
| 1 |
CORYNEBACTERIUM SEPSIS |
3 |
0.0455 |
| 2 |
TREATMENT FAILURE |
1943 |
0.0234 |
| 3 |
DISORDER OF ORBIT |
3 |
0.0208 |
| 4 |
BRACHYCEPHALY |
2 |
0.0198 |
| 5 |
EYELID BLEEDING |
3 |
0.0173 |
| 6 |
EYE DISCHARGE |
178 |
0.0171 |
| 7 |
EXPOSURE TO ALLERGEN |
5 |
0.0157 |
| 8 |
STICKY SKIN |
6 |
0.0150 |
| 9 |
PRODUCT ADVERTISING ISSUE |
3 |
0.0140 |
| 10 |
PIERRE ROBIN SYNDROME |
3 |
0.0140 |
| 11 |
EYELID INFECTION |
6 |
0.0136 |
| 12 |
URTICARIAL VASCULITIS |
7 |
0.0133 |
| 13 |
HUMIDITY INTOLERANCE |
5 |
0.0125 |
| 14 |
AORTIC VALVE THICKENING |
2 |
0.0124 |
| 15 |
PARANASAL CYST |
3 |
0.0123 |
| 16 |
HYPOAESTHESIA EYE |
7 |
0.0119 |
| 17 |
EYELID MARGIN CRUSTING |
34 |
0.0118 |
| 18 |
PRODUCT WITH QUALITY ISSUE ADMINISTERED |
5 |
0.0112 |
| 19 |
KERATOCONUS |
4 |
0.0106 |
| 20 |
THROMBOTIC CEREBRAL INFARCTION |
4 |
0.0106 |
| 21 |
THYROIDITIS SUBACUTE |
3 |
0.0103 |
| 22 |
PATIENT DISSATISFACTION WITH TREATMENT |
19 |
0.0098 |
| 23 |
PRODUCT DELIVERY MECHANISM ISSUE |
53 |
0.0098 |
| 24 |
BLOOD BETA-D-GLUCAN INCREASED |
3 |
0.0098 |
| 25 |
LICHENIFICATION |
4 |
0.0097 |
| 26 |
CONJUNCTIVITIS ALLERGIC |
14 |
0.0094 |
| 27 |
CENTRAL VISION LOSS |
2 |
0.0090 |
| 28 |
ECZEMA HERPETICUM |
4 |
0.0086 |
| 29 |
LIP EROSION |
6 |
0.0082 |
| 30 |
SCLERODERMA RENAL CRISIS |
3 |
0.0079 |
| 31 |
VEIN COLLAPSE |
6 |
0.0078 |
| 32 |
CARDIOVASCULAR SYMPTOM |
3 |
0.0077 |
| 33 |
PRODUCT AFTER TASTE |
7 |
0.0073 |
| 34 |
ANTITHROMBIN III DECREASED |
2 |
0.0073 |
| 35 |
CHEMICAL BURNS OF EYE |
2 |
0.0072 |
| 36 |
MYOFASCIAL PAIN SYNDROME |
5 |
0.0070 |
| 37 |
PRODUCT CLOSURE REMOVAL DIFFICULT |
7 |
0.0069 |
| 38 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
38 |
0.0069 |
| 39 |
ALOPECIA UNIVERSALIS |
2 |
0.0068 |
| 40 |
OCULAR DISCOMFORT |
76 |
0.0068 |
| 41 |
ASPERGILLUS TEST POSITIVE |
2 |
0.0065 |
| 42 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
16 |
0.0065 |
| 43 |
MANUFACTURING ISSUE |
3 |
0.0065 |
| 44 |
EYE ALLERGY |
10 |
0.0065 |
| 45 |
EYELID EXFOLIATION |
5 |
0.0063 |
| 46 |
ALLERGY TO ARTHROPOD BITE |
2 |
0.0063 |
| 47 |
ADMINISTRATION SITE SWELLING |
2 |
0.0062 |
| 48 |
EYELID RASH |
6 |
0.0061 |
| 49 |
UPPER RESPIRATORY TRACT INFLAMMATION |
7 |
0.0058 |
| 50 |
FACIAL DISCOMFORT |
4 |
0.0056 |
| 51 |
PRODUCT OUTER PACKAGING ISSUE |
5 |
0.0055 |
| 52 |
EYE IRRITATION |
314 |
0.0054 |
| 53 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
4 |
0.0052 |
| 54 |
EYELID IRRITATION |
13 |
0.0052 |
| 55 |
ABNORMAL SENSATION IN EYE |
21 |
0.0049 |
| 56 |
LIQUID PRODUCT PHYSICAL ISSUE |
35 |
0.0048 |
| 57 |
SINUSITIS BACTERIAL |
5 |
0.0047 |
| 58 |
PERIORBITAL PAIN |
4 |
0.0047 |
| 59 |
FOREIGN BODY SENSATION IN EYES |
30 |
0.0047 |
| 60 |
EYE PRURITUS |
156 |
0.0046 |
| 61 |
SWELLING OF EYELID |
29 |
0.0046 |
| 62 |
INFUSION SITE DISCHARGE |
8 |
0.0046 |
| 63 |
HEAT ILLNESS |
3 |
0.0044 |
| 64 |
RENAL COLIC |
10 |
0.0044 |
| 65 |
BIOPSY BONE MARROW |
2 |
0.0043 |
| 66 |
PNEUMONIA INFLUENZAL |
5 |
0.0042 |
| 67 |
PRODUCT DESIGN ISSUE |
3 |
0.0042 |
| 68 |
INFUSION SITE BRUISING |
9 |
0.0042 |
| 69 |
INFUSION SITE PRURITUS |
13 |
0.0041 |
| 70 |
ERYTHEMA OF EYELID |
22 |
0.0041 |
| 71 |
MITRAL VALVE DISEASE |
7 |
0.0040 |
| 72 |
EYELID PAIN |
8 |
0.0039 |
| 73 |
AORTIC VALVE CALCIFICATION |
2 |
0.0039 |
| 74 |
SUPERFICIAL INJURY OF EYE |
4 |
0.0037 |
| 75 |
TONGUE ERYTHEMA |
3 |
0.0036 |
| 76 |
DEVICE INFUSION ISSUE |
9 |
0.0036 |
| 77 |
EYELIDS PRURITUS |
11 |
0.0035 |
| 78 |
CRANIOSYNOSTOSIS |
3 |
0.0035 |
| 79 |
THALAMUS HAEMORRHAGE |
3 |
0.0034 |
| 80 |
PRODUCT CONTAINER SEAL ISSUE |
6 |
0.0034 |
| 81 |
EYE PAIN |
189 |
0.0033 |
| 82 |
OCULAR HYPERAEMIA |
157 |
0.0033 |
| 83 |
PUNCTATE KERATITIS |
3 |
0.0033 |
| 84 |
CERVICOBRACHIAL SYNDROME |
2 |
0.0033 |
| 85 |
ORAL MUCOSA EROSION |
4 |
0.0033 |
| 86 |
TONGUE INJURY |
3 |
0.0032 |
| 87 |
PRODUCT PACKAGE ASSOCIATED INJURY |
7 |
0.0031 |
| 88 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
8 |
0.0031 |
| 89 |
LIP INJURY |
4 |
0.0031 |
| 90 |
INFUSION SITE HAEMORRHAGE |
10 |
0.0030 |
| 91 |
SUSPECTED PRODUCT CONTAMINATION |
3 |
0.0030 |
| 92 |
TYMPANIC MEMBRANE PERFORATION |
5 |
0.0030 |
| 93 |
ENTERITIS INFECTIOUS |
5 |
0.0029 |
| 94 |
FULMINANT TYPE 1 DIABETES MELLITUS |
3 |
0.0029 |
| 95 |
BONE MARROW OEDEMA |
3 |
0.0029 |
| 96 |
INFUSION SITE DISCOMFORT |
3 |
0.0029 |
| 97 |
RESPIRATORY TRACT IRRITATION |
3 |
0.0029 |
| 98 |
ALOPECIA AREATA |
5 |
0.0028 |
| 99 |
CHYLOTHORAX |
2 |
0.0028 |
| 100 |
PRODUCT SELECTION ERROR |
3 |
0.0027 |
| 101 |
HYPERURICAEMIA |
11 |
0.0027 |
| 102 |
PERIORBITAL SWELLING |
15 |
0.0027 |
| 103 |
CHOLANGITIS ACUTE |
2 |
0.0026 |
| 104 |
RUBBER SENSITIVITY |
4 |
0.0026 |
| 105 |
ADMINISTRATION SITE PAIN |
3 |
0.0026 |
| 106 |
ERYTHEMA MULTIFORME |
24 |
0.0026 |
| 107 |
IMMUNE-MEDIATED HEPATIC DISORDER |
5 |
0.0026 |
| 108 |
PYELONEPHRITIS ACUTE |
5 |
0.0025 |
| 109 |
BRONCHIAL HYPERREACTIVITY |
3 |
0.0025 |
| 110 |
OTITIS EXTERNA |
3 |
0.0025 |
| 111 |
INFUSION SITE ERYTHEMA |
20 |
0.0024 |
| 112 |
LACRIMATION INCREASED |
71 |
0.0023 |
| 113 |
INFUSION SITE IRRITATION |
3 |
0.0023 |
| 114 |
DERMATITIS EXFOLIATIVE GENERALISED |
8 |
0.0023 |
| 115 |
PEMPHIGOID |
17 |
0.0023 |
| 116 |
RHINITIS ALLERGIC |
10 |
0.0022 |
| 117 |
CYTOMEGALOVIRUS TEST POSITIVE |
4 |
0.0022 |
| 118 |
INFUSION SITE SWELLING |
14 |
0.0022 |
| 119 |
PRODUCT CONTAINER ISSUE |
19 |
0.0022 |
| 120 |
SEASONAL ALLERGY |
31 |
0.0022 |
| 121 |
CERUMEN IMPACTION |
2 |
0.0022 |
| 122 |
EYELID DISORDER |
5 |
0.0022 |
| 123 |
RESPIRATORY TRACT INFECTION VIRAL |
5 |
0.0021 |
| 124 |
EYE SWELLING |
78 |
0.0021 |
| 125 |
POST HERPETIC NEURALGIA |
3 |
0.0021 |
| 126 |
MULTIPLE ALLERGIES |
16 |
0.0020 |
| 127 |
BLOOD IMMUNOGLOBULIN G DECREASED |
5 |
0.0020 |
| 128 |
ALLERGIC REACTION TO EXCIPIENT |
4 |
0.0020 |
| 129 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
3 |
0.0020 |
| 130 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
5 |
0.0020 |
| 131 |
BLOOD PRESSURE DIASTOLIC INCREASED |
9 |
0.0019 |
| 132 |
CHOLANGITIS |
12 |
0.0019 |
| 133 |
ALLERGY TO ANIMAL |
2 |
0.0019 |
| 134 |
AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS |
2 |
0.0019 |
| 135 |
SKIN EROSION |
6 |
0.0019 |
| 136 |
IMMUNE-MEDIATED MYOCARDITIS |
3 |
0.0019 |
| 137 |
VITREOUS DETACHMENT |
4 |
0.0018 |
| 138 |
CONJUNCTIVITIS |
34 |
0.0018 |
| 139 |
ARTHROPOD STING |
3 |
0.0018 |
| 140 |
RESPIRATORY SYMPTOM |
5 |
0.0018 |
| 141 |
DRUG ERUPTION |
31 |
0.0017 |
| 142 |
PRODUCT ODOUR ABNORMAL |
18 |
0.0017 |
| 143 |
VISION BLURRED |
232 |
0.0017 |
| 144 |
DRUG EFFECT LESS THAN EXPECTED |
25 |
0.0017 |
| 145 |
DRY EYE |
84 |
0.0017 |
| 146 |
SKIN WEEPING |
6 |
0.0017 |
| 147 |
INFUSION SITE REACTION |
5 |
0.0017 |
| 148 |
BLOOD IMMUNOGLOBULIN G INCREASED |
2 |
0.0016 |
| 149 |
INFUSION SITE PAIN |
21 |
0.0016 |
| 150 |
WRONG PRODUCT ADMINISTERED |
11 |
0.0016 |
| 151 |
CHRONIC SINUSITIS |
6 |
0.0016 |
| 152 |
WHITE BLOOD CELLS URINE POSITIVE |
3 |
0.0016 |
| 153 |
EYE INFECTION |
18 |
0.0016 |
| 154 |
PARONYCHIA |
7 |
0.0016 |
| 155 |
SACROILIITIS |
3 |
0.0016 |
| 156 |
LIGAMENT RUPTURE |
7 |
0.0016 |
| 157 |
CLEFT PALATE |
3 |
0.0016 |
| 158 |
CONCOMITANT DISEASE PROGRESSION |
3 |
0.0015 |
| 159 |
BLEPHARITIS |
6 |
0.0015 |
| 160 |
PRODUCT SIZE ISSUE |
8 |
0.0015 |
| 161 |
SUDDEN HEARING LOSS |
3 |
0.0015 |
| 162 |
LUNG ABSCESS |
3 |
0.0014 |
| 163 |
BREATH SOUNDS ABNORMAL |
7 |
0.0014 |
| 164 |
EAR SWELLING |
3 |
0.0014 |
| 165 |
TORTICOLLIS |
3 |
0.0014 |
| 166 |
FIBULA FRACTURE |
4 |
0.0014 |
| 167 |
HYPERTONIC BLADDER |
4 |
0.0014 |
| 168 |
PRODUCT COLOUR ISSUE |
7 |
0.0014 |
| 169 |
IMMUNE-MEDIATED ENTEROCOLITIS |
5 |
0.0014 |
| 170 |
PRODUCT LOT NUMBER ISSUE |
3 |
0.0014 |
| 171 |
APRAXIA |
2 |
0.0013 |
| 172 |
METABOLIC ENCEPHALOPATHY |
4 |
0.0013 |
| 173 |
THYROIDITIS |
4 |
0.0013 |
| 174 |
NEPHROGENIC SYSTEMIC FIBROSIS |
4 |
0.0013 |
| 175 |
BLOOD PRESSURE SYSTOLIC DECREASED |
6 |
0.0013 |
| 176 |
EAR DISORDER |
6 |
0.0013 |
| 177 |
FOOD POISONING |
7 |
0.0013 |
| 178 |
ORAL PRURITUS |
3 |
0.0013 |
| 179 |
BLOOD PRESSURE IMMEASURABLE |
2 |
0.0013 |
| 180 |
THERAPEUTIC PRODUCT INEFFECTIVE |
5 |
0.0013 |
| 181 |
MENOPAUSAL SYMPTOMS |
3 |
0.0013 |
| 182 |
HEPATIC FUNCTION ABNORMAL |
48 |
0.0013 |
| 183 |
DYSMORPHISM |
3 |
0.0013 |
| 184 |
SINUS OPERATION |
3 |
0.0013 |
| 185 |
ADRENAL INSUFFICIENCY |
15 |
0.0012 |
| 186 |
PHOTOPHOBIA |
23 |
0.0012 |
| 187 |
POLYP |
8 |
0.0012 |
| 188 |
EOSINOPHIL COUNT INCREASED |
10 |
0.0012 |
| 189 |
CEREBELLAR INFARCTION |
2 |
0.0012 |
| 190 |
BLOOD PH DECREASED |
2 |
0.0012 |
| 191 |
DISSEMINATED TUBERCULOSIS |
3 |
0.0012 |
| 192 |
PHYSICAL DECONDITIONING |
3 |
0.0012 |
| 193 |
ACUTE SINUSITIS |
2 |
0.0012 |
| 194 |
PRODUCT PACKAGING ISSUE |
11 |
0.0012 |
| 195 |
HORDEOLUM |
5 |
0.0012 |
| 196 |
DERMATITIS ACNEIFORM |
7 |
0.0011 |
| 197 |
EMBOLIC STROKE |
4 |
0.0011 |
| 198 |
GLOSSITIS |
4 |
0.0011 |
| 199 |
AORTIC VALVE STENOSIS |
2 |
0.0011 |
| 200 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
3 |
0.0011 |
| 201 |
VASCULAR DEVICE INFECTION |
5 |
0.0011 |
| 202 |
HAEMOGLOBIN INCREASED |
5 |
0.0011 |
| 203 |
SPINAL COMPRESSION FRACTURE |
9 |
0.0011 |
| 204 |
AMYLASE INCREASED |
4 |
0.0011 |
| 205 |
NEPHROGENIC ANAEMIA |
5 |
0.0011 |
| 206 |
PRODUCT USE COMPLAINT |
17 |
0.0011 |
| 207 |
PRODUCT LEAKAGE |
6 |
0.0011 |
| 208 |
IMPULSIVE BEHAVIOUR |
4 |
0.0011 |
| 209 |
DISSEMINATED INTRAVASCULAR COAGULATION |
15 |
0.0011 |
| 210 |
BLOOD PRESSURE FLUCTUATION |
25 |
0.0010 |
| 211 |
UPPER RESPIRATORY TRACT CONGESTION |
3 |
0.0010 |
| 212 |
PRODUCT LABEL ISSUE |
7 |
0.0010 |
| 213 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
3 |
0.0010 |
| 214 |
PERIPHERAL SENSORY NEUROPATHY |
6 |
0.0010 |
| 215 |
BODY TEMPERATURE DECREASED |
10 |
0.0010 |
| 216 |
LIGAMENT SPRAIN |
10 |
0.0010 |
| 217 |
ATYPICAL PNEUMONIA |
3 |
0.0010 |
| 218 |
AZOTAEMIA |
4 |
0.0010 |
| 219 |
OBSTRUCTION |
4 |
0.0010 |
| 220 |
INTERNATIONAL NORMALISED RATIO DECREASED |
4 |
0.0010 |
| 221 |
RECTAL CANCER |
3 |
0.0010 |
| 222 |
INCREASED UPPER AIRWAY SECRETION |
5 |
0.0010 |
| 223 |
CHOLANGITIS SCLEROSING |
2 |
0.0010 |
| 224 |
PHARYNGITIS |
12 |
0.0010 |
| 225 |
POOR VENOUS ACCESS |
10 |
0.0010 |
| 226 |
SINUSITIS |
98 |
0.0010 |
| 227 |
INTERSTITIAL LUNG DISEASE |
46 |
0.0009 |
| 228 |
PHOTOPSIA |
6 |
0.0009 |
| 229 |
EAR INFECTION |
25 |
0.0009 |
| 230 |
PRODUCT DISPENSING ISSUE |
4 |
0.0009 |
| 231 |
HYPOGAMMAGLOBULINAEMIA |
6 |
0.0009 |
| 232 |
NEUTROPHIL COUNT DECREASED |
37 |
0.0009 |
| 233 |
CATHETERISATION CARDIAC |
4 |
0.0009 |
| 234 |
PRODUCT ADMINISTRATION INTERRUPTED |
7 |
0.0009 |
| 235 |
BRONCHIECTASIS |
6 |
0.0009 |
| 236 |
OROPHARYNGEAL DISCOMFORT |
8 |
0.0009 |
| 237 |
BLOOD LOSS ANAEMIA |
2 |
0.0009 |
| 238 |
BRAIN OPERATION |
2 |
0.0009 |
| 239 |
HERPES VIRUS INFECTION |
5 |
0.0009 |
| 240 |
PRODUCTIVE COUGH |
41 |
0.0009 |
| 241 |
EAR PRURITUS |
3 |
0.0009 |
| 242 |
TIBIA FRACTURE |
4 |
0.0009 |
| 243 |
SINUS HEADACHE |
5 |
0.0008 |
| 244 |
EYE INFLAMMATION |
8 |
0.0008 |
| 245 |
PHARYNGITIS STREPTOCOCCAL |
9 |
0.0008 |
| 246 |
MONOCYTE COUNT INCREASED |
3 |
0.0008 |
| 247 |
BLOOD PHOSPHORUS DECREASED |
3 |
0.0008 |
| 248 |
BLOOD PRESSURE SYSTOLIC INCREASED |
16 |
0.0008 |
| 249 |
PSEUDOMONAS INFECTION |
7 |
0.0008 |
| 250 |
VIRAL INFECTION |
27 |
0.0008 |
| 251 |
BRONCHITIS |
60 |
0.0008 |
| 252 |
PULMONARY MASS |
12 |
0.0008 |
| 253 |
PNEUMONIA ASPIRATION |
20 |
0.0008 |
| 254 |
HYPERAMMONAEMIA |
4 |
0.0008 |
| 255 |
CORONARY ARTERY STENOSIS |
4 |
0.0008 |
| 256 |
GASTROINTESTINAL INFECTION |
7 |
0.0008 |
| 257 |
SKIN ULCER |
20 |
0.0008 |
| 258 |
APHTHOUS ULCER |
6 |
0.0008 |
| 259 |
ORAL INFECTION |
3 |
0.0008 |
| 260 |
SKIN FISSURES |
15 |
0.0008 |
| 261 |
ACCIDENTAL OVERDOSE |
28 |
0.0008 |
| 262 |
PNEUMONIA BACTERIAL |
7 |
0.0008 |
| 263 |
VULVOVAGINAL MYCOTIC INFECTION |
3 |
0.0008 |
| 264 |
ORAL CANDIDIASIS |
10 |
0.0008 |
| 265 |
DIVERTICULITIS |
21 |
0.0008 |
| 266 |
SINUS DISORDER |
15 |
0.0008 |
| 267 |
NASAL DISCOMFORT |
6 |
0.0008 |
| 268 |
PRODUCT DISTRIBUTION ISSUE |
7 |
0.0008 |
| 269 |
OESOPHAGEAL CANDIDIASIS |
3 |
0.0008 |
| 270 |
EXPIRED PRODUCT ADMINISTERED |
25 |
0.0008 |
| 271 |
ANIMAL BITE |
2 |
0.0007 |
| 272 |
CHOLECYSTITIS CHRONIC |
5 |
0.0007 |
| 273 |
COMPRESSION FRACTURE |
4 |
0.0007 |
| 274 |
BREAST MASS |
5 |
0.0007 |
| 275 |
FUNGAL SKIN INFECTION |
3 |
0.0007 |
| 276 |
PRODUCT RESIDUE PRESENT |
4 |
0.0007 |
| 277 |
NEURALGIA |
18 |
0.0007 |
| 278 |
POST PROCEDURAL INFECTION |
6 |
0.0007 |
| 279 |
INJECTION SITE EXTRAVASATION |
9 |
0.0007 |
| 280 |
ANAPHYLACTOID REACTION |
3 |
0.0007 |
| 281 |
RED CELL DISTRIBUTION WIDTH INCREASED |
3 |
0.0007 |
| 282 |
SECRETION DISCHARGE |
9 |
0.0007 |
| 283 |
AUTOIMMUNE DISORDER |
7 |
0.0007 |
| 284 |
MACULAR OEDEMA |
4 |
0.0007 |
| 285 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
3 |
0.0007 |
| 286 |
SENSATION OF FOREIGN BODY |
6 |
0.0007 |
| 287 |
RHINORRHOEA |
46 |
0.0007 |
| 288 |
ATYPICAL FEMUR FRACTURE |
2 |
0.0007 |
| 289 |
THERMAL BURN |
5 |
0.0007 |
| 290 |
GENERALISED ERYTHEMA |
4 |
0.0007 |
| 291 |
DERMATITIS CONTACT |
8 |
0.0007 |
| 292 |
SCAB |
8 |
0.0007 |
| 293 |
EXERCISE TOLERANCE DECREASED |
4 |
0.0007 |
| 294 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
11 |
0.0007 |
| 295 |
ALTERED STATE OF CONSCIOUSNESS |
15 |
0.0007 |
| 296 |
MYELODYSPLASTIC SYNDROME |
10 |
0.0007 |
| 297 |
SKIN SWELLING |
6 |
0.0007 |
| 298 |
CHAPPED LIPS |
3 |
0.0007 |
| 299 |
PULMONARY ARTERIAL HYPERTENSION |
10 |
0.0007 |
| 300 |
FUNGAL INFECTION |
23 |
0.0007 |
| 301 |
RALES |
4 |
0.0007 |
| 302 |
PRODUCT LABEL CONFUSION |
4 |
0.0007 |
| 303 |
GASTROENTERITIS |
10 |
0.0007 |
| 304 |
HYPERTRIGLYCERIDAEMIA |
4 |
0.0007 |
| 305 |
BLOOD PRESSURE DIASTOLIC DECREASED |
5 |
0.0007 |
| 306 |
GLUCOSE TOLERANCE IMPAIRED |
4 |
0.0007 |
| 307 |
STEVENS-JOHNSON SYNDROME |
15 |
0.0007 |
| 308 |
EYE HAEMORRHAGE |
9 |
0.0007 |
| 309 |
CYTOMEGALOVIRUS VIRAEMIA |
3 |
0.0007 |
| 310 |
PROTHROMBIN TIME PROLONGED |
4 |
0.0007 |
| 311 |
EAR PAIN |
13 |
0.0007 |
| 312 |
IRON DEFICIENCY |
3 |
0.0007 |
| 313 |
SINUS CONGESTION |
9 |
0.0007 |
| 314 |
TYPE 1 DIABETES MELLITUS |
4 |
0.0007 |
| 315 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
3 |
0.0007 |
| 316 |
CEREBRAL INFARCTION |
16 |
0.0007 |
| 317 |
CANDIDA INFECTION |
11 |
0.0007 |
| 318 |
ROSACEA |
3 |
0.0006 |
| 319 |
BACTERIAL INFECTION |
12 |
0.0006 |
| 320 |
EYE DISORDER |
21 |
0.0006 |
| 321 |
BLOOD CREATININE DECREASED |
2 |
0.0006 |
| 322 |
ASTHMA |
72 |
0.0006 |
| 323 |
BLEPHAROSPASM |
4 |
0.0006 |
| 324 |
RHINITIS |
5 |
0.0006 |
| 325 |
BACTERIAL SEPSIS |
2 |
0.0006 |
| 326 |
INCORRECT DOSAGE ADMINISTERED |
3 |
0.0006 |
| 327 |
NASAL POLYPS |
3 |
0.0006 |
| 328 |
STAPHYLOCOCCAL SEPSIS |
3 |
0.0006 |
| 329 |
TOOTH INFECTION |
8 |
0.0006 |
| 330 |
ORGANISING PNEUMONIA |
3 |
0.0006 |
| 331 |
HYPERSENSITIVITY |
112 |
0.0006 |
| 332 |
MADAROSIS |
7 |
0.0006 |
| 333 |
FLUID INTAKE REDUCED |
3 |
0.0006 |
| 334 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
6 |
0.0006 |
| 335 |
TOXIC SKIN ERUPTION |
6 |
0.0006 |
| 336 |
NASAL CONGESTION |
35 |
0.0006 |
| 337 |
TOXIC ENCEPHALOPATHY |
3 |
0.0006 |
| 338 |
MIDDLE INSOMNIA |
11 |
0.0006 |
| 339 |
PHLEBITIS |
3 |
0.0006 |
| 340 |
RENAL IMPAIRMENT |
49 |
0.0006 |
| 341 |
MUSCLE STRAIN |
5 |
0.0006 |
| 342 |
PYELONEPHRITIS |
5 |
0.0006 |
| 343 |
TENDERNESS |
6 |
0.0006 |
| 344 |
BRONCHIOLITIS |
2 |
0.0006 |
| 345 |
PNEUMOTHORAX |
9 |
0.0006 |
| 346 |
PULMONARY TOXICITY |
4 |
0.0006 |
| 347 |
ORAL HERPES |
11 |
0.0006 |
| 348 |
BODY HEIGHT DECREASED |
6 |
0.0006 |
| 349 |
HEREDITARY ANGIOEDEMA |
6 |
0.0006 |
| 350 |
GINGIVITIS |
3 |
0.0006 |
| 351 |
CELLULITIS |
28 |
0.0006 |
| 352 |
ECZEMA |
29 |
0.0006 |
| 353 |
LIMB INJURY |
15 |
0.0006 |
| 354 |
ASTHENOPIA |
3 |
0.0005 |
| 355 |
SKIN HAEMORRHAGE |
8 |
0.0005 |
| 356 |
HEPATIC STEATOSIS |
10 |
0.0005 |
| 357 |
BLOOD CHOLESTEROL INCREASED |
25 |
0.0005 |
| 358 |
DYSPNOEA EXERTIONAL |
20 |
0.0005 |
| 359 |
PULMONARY CONGESTION |
7 |
0.0005 |
| 360 |
REBOUND EFFECT |
6 |
0.0005 |
| 361 |
MITRAL VALVE INCOMPETENCE |
6 |
0.0005 |
| 362 |
CHOLECYSTITIS ACUTE |
3 |
0.0005 |
| 363 |
ADVERSE REACTION |
7 |
0.0005 |
| 364 |
FEBRILE NEUTROPENIA |
35 |
0.0005 |
| 365 |
INTERNAL HAEMORRHAGE |
6 |
0.0005 |
| 366 |
INSURANCE ISSUE |
8 |
0.0005 |
| 367 |
C-REACTIVE PROTEIN INCREASED |
19 |
0.0005 |
| 368 |
DEVICE RELATED INFECTION |
8 |
0.0005 |
| 369 |
EYELID OEDEMA |
6 |
0.0005 |
| 370 |
UVEITIS |
7 |
0.0005 |
| 371 |
SKIN WARM |
3 |
0.0005 |
| 372 |
ACUTE MYELOID LEUKAEMIA |
8 |
0.0005 |
| 373 |
BLOOD PRESSURE DECREASED |
34 |
0.0005 |
| 374 |
COVID-19 PNEUMONIA |
6 |
0.0005 |
| 375 |
BLOOD ALBUMIN DECREASED |
4 |
0.0005 |
| 376 |
MELAENA |
11 |
0.0005 |
| 377 |
CYTOKINE RELEASE SYNDROME |
10 |
0.0005 |
| 378 |
RESTLESS LEGS SYNDROME |
9 |
0.0005 |
| 379 |
PRODUCT ADMINISTRATION ERROR |
10 |
0.0005 |
| 380 |
TASTE DISORDER |
10 |
0.0005 |
| 381 |
ASPHYXIA |
4 |
0.0005 |
| 382 |
INITIAL INSOMNIA |
5 |
0.0005 |
| 383 |
CONCOMITANT DISEASE AGGRAVATED |
3 |
0.0005 |
| 384 |
UPPER-AIRWAY COUGH SYNDROME |
4 |
0.0005 |
| 385 |
ILLNESS |
50 |
0.0005 |
| 386 |
AORTIC DISSECTION |
2 |
0.0005 |
| 387 |
INFUSION RELATED REACTION |
32 |
0.0005 |
| 388 |
INFUSION SITE EXTRAVASATION |
3 |
0.0005 |
| 389 |
NASAL DRYNESS |
3 |
0.0005 |
| 390 |
DRUG-INDUCED LIVER INJURY |
15 |
0.0005 |
| 391 |
BLOOD UREA INCREASED |
8 |
0.0005 |
| 392 |
FOOT FRACTURE |
9 |
0.0005 |
| 393 |
LIVER DISORDER |
21 |
0.0005 |
| 394 |
BUNDLE BRANCH BLOCK LEFT |
2 |
0.0005 |
| 395 |
SLEEP APNOEA SYNDROME |
9 |
0.0005 |
| 396 |
INTRAOCULAR PRESSURE INCREASED |
6 |
0.0005 |
| 397 |
CARDIAC FAILURE CHRONIC |
2 |
0.0005 |
| 398 |
ENTERITIS |
3 |
0.0005 |
| 399 |
INFLUENZA |
52 |
0.0005 |
| 400 |
CARDIAC FLUTTER |
3 |
0.0005 |
| 401 |
CARDIAC MURMUR |
4 |
0.0005 |
| 402 |
DEVICE DEFECTIVE |
8 |
0.0005 |
| 403 |
RESPIRATORY TRACT INFECTION |
12 |
0.0005 |
| 404 |
SKIN LACERATION |
5 |
0.0005 |
| 405 |
INTENTIONAL DOSE OMISSION |
13 |
0.0005 |
| 406 |
DRUG INEFFECTIVE |
600 |
0.0005 |
| 407 |
LOCALISED INFECTION |
11 |
0.0005 |
| 408 |
TUMOUR LYSIS SYNDROME |
4 |
0.0005 |
| 409 |
UPPER RESPIRATORY TRACT INFECTION |
21 |
0.0005 |
| 410 |
SARS-COV-2 TEST POSITIVE |
6 |
0.0005 |
| 411 |
HERPES ZOSTER |
26 |
0.0005 |
| 412 |
PRESCRIBED UNDERDOSE |
9 |
0.0005 |
| 413 |
CARDIAC FAILURE ACUTE |
3 |
0.0004 |
| 414 |
SKIN MASS |
3 |
0.0004 |
| 415 |
ATRIOVENTRICULAR BLOCK COMPLETE |
3 |
0.0004 |
| 416 |
BRAIN FOG |
7 |
0.0004 |
| 417 |
INTESTINAL PERFORATION |
5 |
0.0004 |
| 418 |
OXYGEN SATURATION DECREASED |
25 |
0.0004 |
| 419 |
COLITIS ISCHAEMIC |
3 |
0.0004 |
| 420 |
DEVELOPMENTAL DELAY |
4 |
0.0004 |
| 421 |
TOOTHACHE |
8 |
0.0004 |
| 422 |
SCIATICA |
7 |
0.0004 |
| 423 |
NEPHROTIC SYNDROME |
3 |
0.0004 |
| 424 |
NEOPLASM |
5 |
0.0004 |
| 425 |
RESPIRATORY DISORDER |
13 |
0.0004 |
| 426 |
BLOOD GLUCOSE ABNORMAL |
8 |
0.0004 |
| 427 |
PLATELET COUNT DECREASED |
46 |
0.0004 |
| 428 |
AUTOIMMUNE HEPATITIS |
3 |
0.0004 |
| 429 |
BACK DISORDER |
7 |
0.0004 |
| 430 |
APPENDICITIS |
4 |
0.0004 |
| 431 |
DEFAECATION URGENCY |
3 |
0.0004 |
| 432 |
TUBULOINTERSTITIAL NEPHRITIS |
8 |
0.0004 |
| 433 |
ARTERIOSCLEROSIS |
4 |
0.0004 |
| 434 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
19 |
0.0004 |
| 435 |
RETINAL HAEMORRHAGE |
3 |
0.0004 |
| 436 |
CHOLECYSTITIS |
5 |
0.0004 |
| 437 |
GASTRITIS |
11 |
0.0004 |
| 438 |
WRIST FRACTURE |
5 |
0.0004 |
| 439 |
ANAPHYLACTIC REACTION |
23 |
0.0004 |
| 440 |
DERMATITIS BULLOUS |
3 |
0.0004 |
| 441 |
FAECES SOFT |
3 |
0.0004 |
| 442 |
COUGH |
114 |
0.0004 |
| 443 |
SPINAL OPERATION |
5 |
0.0004 |
| 444 |
OEDEMA |
22 |
0.0004 |
| 445 |
GENERALISED OEDEMA |
5 |
0.0004 |
| 446 |
ILEUS |
5 |
0.0004 |
| 447 |
ANEURYSM |
2 |
0.0004 |
| 448 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 |
0.0004 |
| 449 |
DERMATITIS ATOPIC |
21 |
0.0004 |
| 450 |
PAROSMIA |
3 |
0.0004 |
| 451 |
HYPOXIA |
14 |
0.0004 |
| 452 |
HEPATOCELLULAR CARCINOMA |
3 |
0.0004 |
| 453 |
FEEDING DISORDER |
8 |
0.0004 |
| 454 |
STAPHYLOCOCCAL INFECTION |
13 |
0.0004 |
| 455 |
ACIDOSIS |
3 |
0.0004 |
| 456 |
THIRST |
7 |
0.0004 |
| 457 |
DEVICE PHYSICAL PROPERTY ISSUE |
3 |
0.0004 |
| 458 |
LIPASE INCREASED |
3 |
0.0004 |
| 459 |
CONDITION AGGRAVATED |
119 |
0.0004 |
| 460 |
HYPOPHAGIA |
10 |
0.0004 |
| 461 |
NEUTROPHIL COUNT INCREASED |
4 |
0.0004 |
| 462 |
NASOPHARYNGITIS |
72 |
0.0004 |
| 463 |
EUPHORIC MOOD |
4 |
0.0004 |
| 464 |
EAR DISCOMFORT |
4 |
0.0004 |
| 465 |
ROTATOR CUFF SYNDROME |
5 |
0.0004 |
| 466 |
OROPHARYNGEAL PAIN |
36 |
0.0004 |
| 467 |
FOOD ALLERGY |
3 |
0.0004 |
| 468 |
ANKLE FRACTURE |
6 |
0.0004 |
| 469 |
RASH GENERALISED |
10 |
0.0004 |
| 470 |
HYPOALBUMINAEMIA |
3 |
0.0004 |
| 471 |
GASTROINTESTINAL INFLAMMATION |
3 |
0.0004 |
| 472 |
ELECTROCARDIOGRAM ABNORMAL |
3 |
0.0004 |
| 473 |
WEIGHT FLUCTUATION |
4 |
0.0004 |
| 474 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
11 |
0.0004 |
| 475 |
CYANOSIS |
6 |
0.0004 |
| 476 |
HYPOTHYROIDISM |
12 |
0.0004 |
| 477 |
ANAL FISSURE |
2 |
0.0004 |
| 478 |
FRUSTRATION TOLERANCE DECREASED |
3 |
0.0004 |
| 479 |
ANAL ABSCESS |
2 |
0.0004 |
| 480 |
WHEEZING |
22 |
0.0004 |
| 481 |
FIBROMYALGIA |
9 |
0.0004 |
| 482 |
BLOOD BILIRUBIN INCREASED |
10 |
0.0004 |
| 483 |
PRESYNCOPE |
9 |
0.0004 |
| 484 |
TINNITUS |
17 |
0.0004 |
| 485 |
BLOOD POTASSIUM INCREASED |
6 |
0.0004 |
| 486 |
HYPOKALAEMIA |
17 |
0.0004 |
| 487 |
GASTRIC ULCER |
7 |
0.0004 |
| 488 |
HICCUPS |
3 |
0.0004 |
| 489 |
CONTRAINDICATED PRODUCT ADMINISTERED |
11 |
0.0004 |
| 490 |
THERAPEUTIC RESPONSE SHORTENED |
12 |
0.0004 |
| 491 |
EMBOLISM |
3 |
0.0004 |
| 492 |
CARDIAC FAILURE |
29 |
0.0004 |
| 493 |
ORAL DISCOMFORT |
5 |
0.0004 |
| 494 |
WHITE BLOOD CELL COUNT DECREASED |
39 |
0.0004 |
| 495 |
HYPOMAGNESAEMIA |
5 |
0.0004 |
| 496 |
ALANINE AMINOTRANSFERASE INCREASED |
22 |
0.0004 |
| 497 |
URINARY TRACT INFECTION |
61 |
0.0004 |
| 498 |
KIDNEY INFECTION |
7 |
0.0004 |
| 499 |
SKIN INFECTION |
4 |
0.0004 |
| 500 |
TYPE 2 DIABETES MELLITUS |
12 |
0.0004 |
| 501 |
PNEUMONIA |
115 |
0.0004 |
| 502 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
6 |
0.0004 |
| 503 |
PRODUCT AVAILABILITY ISSUE |
8 |
0.0004 |
| 504 |
PYREXIA |
121 |
0.0003 |
| 505 |
EXPOSURE VIA SKIN CONTACT |
9 |
0.0003 |
| 506 |
HYSTERECTOMY |
3 |
0.0003 |
| 507 |
CYSTITIS |
11 |
0.0003 |
| 508 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
3 |
0.0003 |
| 509 |
ELECTROLYTE IMBALANCE |
4 |
0.0003 |
| 510 |
NAIL DISORDER |
3 |
0.0003 |
| 511 |
EOSINOPHILIA |
6 |
0.0003 |
| 512 |
LYMPHOCYTE COUNT DECREASED |
6 |
0.0003 |
| 513 |
LYMPHADENOPATHY |
12 |
0.0003 |
| 514 |
VISUAL IMPAIRMENT |
42 |
0.0003 |
| 515 |
BLOOD IRON DECREASED |
4 |
0.0003 |
| 516 |
ATAXIA |
4 |
0.0003 |
| 517 |
BACTERAEMIA |
4 |
0.0003 |
| 518 |
PRODUCT DOSE OMISSION ISSUE |
99 |
0.0003 |
| 519 |
DYSGEUSIA |
25 |
0.0003 |
| 520 |
ACCIDENT |
4 |
0.0003 |
| 521 |
HAEMOLYTIC ANAEMIA |
3 |
0.0003 |
| 522 |
CHEST DISCOMFORT |
34 |
0.0003 |
| 523 |
BLOOD COUNT ABNORMAL |
5 |
0.0003 |
| 524 |
TOXIC EPIDERMAL NECROLYSIS |
5 |
0.0003 |
| 525 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
13 |
0.0003 |
| 526 |
IRRITABLE BOWEL SYNDROME |
7 |
0.0003 |
| 527 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
3 |
0.0003 |
| 528 |
UROSEPSIS |
3 |
0.0003 |
| 529 |
COVID-19 |
57 |
0.0003 |
| 530 |
MIGRAINE |
31 |
0.0003 |
| 531 |
INTERVERTEBRAL DISC DEGENERATION |
3 |
0.0003 |
| 532 |
PRURITUS |
124 |
0.0003 |
| 533 |
WOUND |
9 |
0.0003 |
| 534 |
SEPTIC SHOCK |
14 |
0.0003 |
| 535 |
HEPATIC ENCEPHALOPATHY |
3 |
0.0003 |
| 536 |
DIARRHOEA HAEMORRHAGIC |
3 |
0.0003 |
| 537 |
EPISTAXIS |
24 |
0.0003 |
| 538 |
CARDIAC DISORDER |
30 |
0.0003 |
| 539 |
INJECTION SITE DISCOLOURATION |
4 |
0.0003 |
| 540 |
ASPARTATE AMINOTRANSFERASE INCREASED |
17 |
0.0003 |
| 541 |
SKIN EXFOLIATION |
27 |
0.0003 |
| 542 |
BLOOD SODIUM DECREASED |
6 |
0.0003 |
| 543 |
DERMATITIS ALLERGIC |
4 |
0.0003 |
| 544 |
HYPOCALCAEMIA |
6 |
0.0003 |
| 545 |
DELIRIUM |
11 |
0.0003 |
| 546 |
PROTEINURIA |
6 |
0.0003 |
| 547 |
FEELING JITTERY |
6 |
0.0003 |
| 548 |
RESPIRATORY TRACT CONGESTION |
5 |
0.0003 |
| 549 |
DRY SKIN |
42 |
0.0003 |
| 550 |
RASH MACULAR |
11 |
0.0003 |
| 551 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
3 |
0.0003 |
| 552 |
SEPSIS |
35 |
0.0003 |
| 553 |
SUPRAVENTRICULAR TACHYCARDIA |
3 |
0.0003 |
| 554 |
PRODUCT SUBSTITUTION ISSUE |
18 |
0.0003 |
| 555 |
C-REACTIVE PROTEIN ABNORMAL |
2 |
0.0003 |
| 556 |
CHROMATURIA |
7 |
0.0003 |
| 557 |
DECREASED APPETITE |
72 |
0.0003 |
| 558 |
INJECTION SITE INDURATION |
4 |
0.0003 |
| 559 |
HAEMORRHOIDS |
6 |
0.0003 |
| 560 |
PHARYNGEAL SWELLING |
3 |
0.0003 |
| 561 |
ERYTHEMA |
63 |
0.0003 |
| 562 |
COELIAC DISEASE |
3 |
0.0003 |
| 563 |
VITREOUS FLOATERS |
3 |
0.0003 |
| 564 |
SHOCK |
7 |
0.0003 |
| 565 |
WEIGHT INCREASED |
68 |
0.0003 |
| 566 |
BLOOD PRESSURE ABNORMAL |
6 |
0.0003 |
| 567 |
CYTOMEGALOVIRUS INFECTION |
5 |
0.0003 |
| 568 |
URINARY RETENTION |
10 |
0.0003 |
| 569 |
BLOOD POTASSIUM DECREASED |
9 |
0.0003 |
| 570 |
HEPATIC FAILURE |
9 |
0.0003 |
| 571 |
HEADACHE |
187 |
0.0003 |
| 572 |
RASH |
129 |
0.0003 |
| 573 |
ANAEMIA |
56 |
0.0003 |
| 574 |
HEART RATE INCREASED |
29 |
0.0003 |
| 575 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
3 |
0.0003 |
| 576 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
5 |
0.0003 |
| 577 |
INFLUENZA LIKE ILLNESS |
24 |
0.0003 |
| 578 |
MUSCULOSKELETAL DISCOMFORT |
5 |
0.0003 |
| 579 |
THROAT IRRITATION |
13 |
0.0003 |
| 580 |
HYPERBILIRUBINAEMIA |
3 |
0.0003 |
| 581 |
THERAPY NON-RESPONDER |
13 |
0.0003 |
| 582 |
HAEMOPTYSIS |
8 |
0.0003 |
| 583 |
NECK PAIN |
16 |
0.0003 |
| 584 |
LUNG DISORDER |
14 |
0.0003 |
| 585 |
CATARACT |
17 |
0.0003 |
| 586 |
INJECTION SITE DISCOMFORT |
3 |
0.0003 |
| 587 |
SCRATCH |
3 |
0.0003 |
| 588 |
COLD SWEAT |
5 |
0.0003 |
| 589 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
7 |
0.0003 |
| 590 |
STOMATITIS |
17 |
0.0003 |
| 591 |
GALLBLADDER DISORDER |
5 |
0.0003 |
| 592 |
PARAESTHESIA ORAL |
4 |
0.0003 |
| 593 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
6 |
0.0003 |
| 594 |
DEVICE LEAKAGE |
12 |
0.0003 |
| 595 |
PRODUCT DISPENSING ERROR |
6 |
0.0003 |
| 596 |
OESOPHAGITIS |
3 |
0.0003 |
| 597 |
JOINT SWELLING |
33 |
0.0003 |
| 598 |
ASCITES |
8 |
0.0003 |
| 599 |
RASH ERYTHEMATOUS |
13 |
0.0003 |
| 600 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
49 |
0.0003 |
| 601 |
ANAPHYLACTIC SHOCK |
7 |
0.0003 |
| 602 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
| 603 |
OEDEMA PERIPHERAL |
33 |
0.0003 |
| 604 |
FOOT DEFORMITY |
3 |
0.0003 |
| 605 |
LIP SWELLING |
9 |
0.0003 |
| 606 |
ARTHROPOD BITE |
2 |
0.0003 |
| 607 |
RASH MACULO-PAPULAR |
6 |
0.0003 |
| 608 |
URTICARIA |
45 |
0.0003 |
| 609 |
DEAFNESS |
7 |
0.0003 |
| 610 |
HEPATIC CIRRHOSIS |
5 |
0.0003 |
| 611 |
INTESTINAL OBSTRUCTION |
10 |
0.0003 |
| 612 |
MALAISE |
116 |
0.0003 |
| 613 |
PLEURAL EFFUSION |
16 |
0.0003 |
| 614 |
CHOLECYSTECTOMY |
3 |
0.0003 |
| 615 |
BOWEL MOVEMENT IRREGULARITY |
2 |
0.0003 |
| 616 |
INJECTION SITE SWELLING |
20 |
0.0003 |
| 617 |
GASTROOESOPHAGEAL REFLUX DISEASE |
21 |
0.0003 |
| 618 |
POST PROCEDURAL COMPLICATION |
5 |
0.0003 |
| 619 |
FEAR |
7 |
0.0003 |
| 620 |
JAUNDICE |
7 |
0.0003 |
| 621 |
METASTASES TO LUNG |
3 |
0.0003 |
| 622 |
PERICARDIAL EFFUSION |
6 |
0.0003 |
| 623 |
CAESAREAN SECTION |
3 |
0.0003 |
| 624 |
VASCULITIS |
3 |
0.0003 |
| 625 |
DELUSION |
4 |
0.0003 |
| 626 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
2 |
0.0003 |
| 627 |
HYPERKALAEMIA |
9 |
0.0003 |
| 628 |
THERAPY PARTIAL RESPONDER |
4 |
0.0003 |
| 629 |
CHOKING |
5 |
0.0003 |
| 630 |
SURGERY |
15 |
0.0003 |
| 631 |
MYOCLONUS |
3 |
0.0003 |
| 632 |
MACULAR DEGENERATION |
3 |
0.0003 |
| 633 |
UPPER LIMB FRACTURE |
5 |
0.0003 |
| 634 |
PANCYTOPENIA |
14 |
0.0003 |
| 635 |
MYELOSUPPRESSION |
9 |
0.0002 |
| 636 |
HEPATIC ENZYME INCREASED |
17 |
0.0002 |
| 637 |
PRODUCT DOSE OMISSION IN ERROR |
7 |
0.0002 |
| 638 |
NOCTURIA |
3 |
0.0002 |
| 639 |
SCHIZOPHRENIA |
3 |
0.0002 |
| 640 |
INTERNATIONAL NORMALISED RATIO INCREASED |
7 |
0.0002 |
| 641 |
CYTOPENIA |
3 |
0.0002 |
| 642 |
ENCEPHALOPATHY |
6 |
0.0002 |
| 643 |
GLOMERULAR FILTRATION RATE DECREASED |
3 |
0.0002 |
| 644 |
SMALL INTESTINAL OBSTRUCTION |
3 |
0.0002 |
| 645 |
OSTEOPOROSIS |
10 |
0.0002 |
| 646 |
CYST |
3 |
0.0002 |
| 647 |
SLEEP DISORDER |
17 |
0.0002 |
| 648 |
DEHYDRATION |
32 |
0.0002 |
| 649 |
RHABDOMYOLYSIS |
10 |
0.0002 |
| 650 |
DYSPHONIA |
14 |
0.0002 |
| 651 |
INJECTION SITE PRURITUS |
16 |
0.0002 |
| 652 |
DERMATITIS |
5 |
0.0002 |
| 653 |
BRAIN OEDEMA |
3 |
0.0002 |
| 654 |
FACE OEDEMA |
4 |
0.0002 |
| 655 |
HAEMATEMESIS |
6 |
0.0002 |
| 656 |
PRODUCT QUALITY ISSUE |
32 |
0.0002 |
| 657 |
CIRCULATORY COLLAPSE |
4 |
0.0002 |
| 658 |
PRODUCT USE ISSUE |
44 |
0.0002 |
| 659 |
MYDRIASIS |
3 |
0.0002 |
| 660 |
ANURIA |
2 |
0.0002 |
| 661 |
HIATUS HERNIA |
3 |
0.0002 |
| 662 |
FAECES DISCOLOURED |
5 |
0.0002 |
| 663 |
BLOOD CREATININE INCREASED |
15 |
0.0002 |
| 664 |
CLOSTRIDIUM DIFFICILE INFECTION |
5 |
0.0002 |
| 665 |
DIZZINESS |
114 |
0.0002 |
| 666 |
ANKYLOSING SPONDYLITIS |
3 |
0.0002 |
| 667 |
PRODUCT USE IN UNAPPROVED INDICATION |
56 |
0.0002 |
| 668 |
HEAD DISCOMFORT |
4 |
0.0002 |
| 669 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
5 |
0.0002 |
| 670 |
MALIGNANT NEOPLASM PROGRESSION |
23 |
0.0002 |
| 671 |
CEREBRAL HAEMORRHAGE |
8 |
0.0002 |
| 672 |
SNEEZING |
5 |
0.0002 |
| 673 |
PAIN OF SKIN |
6 |
0.0002 |
| 674 |
PANCREATITIS ACUTE |
5 |
0.0002 |
| 675 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
45 |
0.0002 |
| 676 |
HYPERTENSION |
47 |
0.0002 |
| 677 |
THROAT TIGHTNESS |
6 |
0.0002 |
| 678 |
PRODUCT TASTE ABNORMAL |
3 |
0.0002 |
| 679 |
INSOMNIA |
59 |
0.0002 |
| 680 |
ARTHRALGIA |
92 |
0.0002 |
| 681 |
NO ADVERSE EVENT |
40 |
0.0002 |
| 682 |
PERIPHERAL SWELLING |
34 |
0.0002 |
| 683 |
PALLOR |
6 |
0.0002 |
| 684 |
LEUKOPENIA |
11 |
0.0002 |
| 685 |
GINGIVAL BLEEDING |
3 |
0.0002 |
| 686 |
BACK PAIN |
51 |
0.0002 |
| 687 |
RESTLESSNESS |
8 |
0.0002 |
| 688 |
PERIPHERAL COLDNESS |
3 |
0.0002 |
| 689 |
INJECTION SITE MASS |
8 |
0.0002 |
| 690 |
ATRIAL FIBRILLATION |
21 |
0.0002 |
| 691 |
APHONIA |
3 |
0.0002 |
| 692 |
WEIGHT DECREASED |
60 |
0.0002 |
| 693 |
HAEMOGLOBIN DECREASED |
22 |
0.0002 |
| 694 |
BLISTER |
12 |
0.0002 |
| 695 |
FEELING ABNORMAL |
51 |
0.0002 |
| 696 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
6 |
0.0002 |
| 697 |
BLOOD URINE PRESENT |
4 |
0.0002 |
| 698 |
BRONCHOSPASM |
3 |
0.0002 |
| 699 |
SUBDURAL HAEMATOMA |
3 |
0.0002 |
| 700 |
DRY MOUTH |
17 |
0.0002 |
| 701 |
WHITE BLOOD CELL COUNT INCREASED |
8 |
0.0002 |
| 702 |
GLAUCOMA |
4 |
0.0002 |
| 703 |
DIARRHOEA |
134 |
0.0002 |
| 704 |
PRESCRIBED OVERDOSE |
4 |
0.0002 |
| 705 |
INJECTION SITE URTICARIA |
5 |
0.0002 |
| 706 |
DYSPNOEA |
115 |
0.0002 |
| 707 |
SWELLING |
19 |
0.0002 |
| 708 |
BLOOD PRESSURE INCREASED |
31 |
0.0002 |
| 709 |
TACHYCARDIA |
18 |
0.0002 |
| 710 |
ABNORMAL BEHAVIOUR |
8 |
0.0002 |
| 711 |
BLADDER DISORDER |
2 |
0.0002 |
| 712 |
DEEP VEIN THROMBOSIS |
13 |
0.0002 |
| 713 |
SWELLING FACE |
13 |
0.0002 |
| 714 |
BURNING SENSATION |
14 |
0.0002 |
| 715 |
BRAIN INJURY |
2 |
0.0002 |
| 716 |
HOT FLUSH |
15 |
0.0002 |
| 717 |
HYPOAESTHESIA ORAL |
3 |
0.0002 |
| 718 |
THERAPEUTIC RESPONSE DECREASED |
12 |
0.0002 |
| 719 |
EXTRA DOSE ADMINISTERED |
8 |
0.0002 |
| 720 |
PRODUCT COMPLAINT |
5 |
0.0002 |
| 721 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
7 |
0.0002 |
| 722 |
DEVICE FAILURE |
3 |
0.0002 |
| 723 |
SKIN IRRITATION |
9 |
0.0002 |
| 724 |
RIB FRACTURE |
4 |
0.0002 |
| 725 |
LYMPHOMA |
3 |
0.0002 |
| 726 |
MUSCULOSKELETAL CHEST PAIN |
3 |
0.0002 |
| 727 |
HYPOAESTHESIA |
29 |
0.0002 |
| 728 |
MUSCULAR WEAKNESS |
22 |
0.0002 |
| 729 |
LUNG INFECTION |
3 |
0.0002 |
| 730 |
CRYING |
7 |
0.0002 |
| 731 |
CONSTIPATION |
42 |
0.0002 |
| 732 |
DIPLOPIA |
5 |
0.0002 |
| 733 |
PANIC ATTACK |
7 |
0.0002 |
| 734 |
POLLAKIURIA |
8 |
0.0002 |
| 735 |
ABDOMINAL DISTENSION |
20 |
0.0002 |
| 736 |
MOUTH ULCERATION |
4 |
0.0002 |
| 737 |
DYSPHAGIA |
18 |
0.0002 |
| 738 |
HEAD INJURY |
6 |
0.0002 |
| 739 |
NAUSEA |
150 |
0.0002 |
| 740 |
OSTEOARTHRITIS |
8 |
0.0002 |
| 741 |
CLOSTRIDIUM DIFFICILE COLITIS |
2 |
0.0002 |
| 742 |
ULCER |
3 |
0.0002 |
| 743 |
EATING DISORDER |
4 |
0.0002 |
| 744 |
PALPITATIONS |
22 |
0.0002 |
| 745 |
RETCHING |
4 |
0.0002 |
| 746 |
CARDIAC FAILURE CONGESTIVE |
15 |
0.0002 |
| 747 |
PAIN IN EXTREMITY |
55 |
0.0002 |
| 748 |
FALL |
62 |
0.0002 |
| 749 |
POOR QUALITY SLEEP |
4 |
0.0002 |
| 750 |
LACTIC ACIDOSIS |
6 |
0.0002 |
| 751 |
RASH PRURITIC |
10 |
0.0002 |
| 752 |
HYPOTENSION |
37 |
0.0002 |
| 753 |
METASTASES TO BONE |
3 |
0.0002 |
| 754 |
PHOTOSENSITIVITY REACTION |
3 |
0.0002 |
| 755 |
GENERALISED TONIC-CLONIC SEIZURE |
3 |
0.0002 |
| 756 |
DISCOMFORT |
11 |
0.0002 |
| 757 |
PROCEDURAL PAIN |
5 |
0.0002 |
| 758 |
MUSCLE SPASMS |
33 |
0.0002 |
| 759 |
GAIT INABILITY |
6 |
0.0002 |
| 760 |
FEELING HOT |
11 |
0.0002 |
| 761 |
DEMENTIA |
5 |
0.0002 |
| 762 |
ABDOMINAL DISCOMFORT |
30 |
0.0002 |
| 763 |
GASTROINTESTINAL DISORDER |
16 |
0.0002 |
| 764 |
FLUSHING |
18 |
0.0002 |
| 765 |
HEART RATE IRREGULAR |
4 |
0.0002 |
| 766 |
FLUID RETENTION |
9 |
0.0002 |
| 767 |
PAIN IN JAW |
5 |
0.0002 |
| 768 |
RED BLOOD CELL COUNT DECREASED |
5 |
0.0002 |
| 769 |
NEPHROLITHIASIS |
8 |
0.0002 |
| 770 |
VOMITING |
82 |
0.0002 |
| 771 |
INFLAMMATION |
9 |
0.0002 |
| 772 |
PAIN |
107 |
0.0002 |
| 773 |
MULTI-ORGAN FAILURE |
3 |
0.0002 |
| 774 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
9 |
0.0002 |
| 775 |
GAIT DISTURBANCE |
33 |
0.0002 |
| 776 |
ORTHOSTATIC HYPOTENSION |
3 |
0.0002 |
| 777 |
BLINDNESS |
7 |
0.0002 |
| 778 |
MUSCULOSKELETAL PAIN |
9 |
0.0002 |
| 779 |
RENAL DISORDER |
8 |
0.0002 |
| 780 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
4 |
0.0002 |
| 781 |
DEVICE USE ISSUE |
3 |
0.0002 |
| 782 |
HEART RATE DECREASED |
6 |
0.0002 |
| 783 |
THROMBOCYTOPENIA |
19 |
0.0002 |
| 784 |
BLOOD TRIGLYCERIDES INCREASED |
3 |
0.0002 |
| 785 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
3 |
0.0002 |
| 786 |
LABORATORY TEST ABNORMAL |
5 |
0.0002 |
| 787 |
URINARY INCONTINENCE |
5 |
0.0002 |
| 788 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
12 |
0.0002 |
| 789 |
NEUROPATHY PERIPHERAL |
16 |
0.0002 |
| 790 |
COMA |
8 |
0.0002 |
| 791 |
PRODUCT PRESCRIBING ERROR |
4 |
0.0002 |
| 792 |
CARDIO-RESPIRATORY ARREST |
7 |
0.0002 |
| 793 |
RHEUMATOID ARTHRITIS |
19 |
0.0002 |
| 794 |
FATIGUE |
130 |
0.0002 |
| 795 |
SYNOVITIS |
3 |
0.0002 |
| 796 |
IRRITABILITY |
10 |
0.0002 |
| 797 |
GASTROENTERITIS VIRAL |
3 |
0.0002 |
| 798 |
ARTHRITIS |
13 |
0.0002 |
| 799 |
BURSITIS |
2 |
0.0002 |
| 800 |
HYPERGLYCAEMIA |
6 |
0.0002 |
| 801 |
UNDERDOSE |
12 |
0.0002 |
| 802 |
EPILEPSY |
5 |
0.0002 |
| 803 |
INJECTION SITE RASH |
5 |
0.0002 |
| 804 |
INJECTION SITE BRUISING |
13 |
0.0002 |
| 805 |
RECTAL HAEMORRHAGE |
7 |
0.0002 |
| 806 |
CARDIOMEGALY |
2 |
0.0002 |
| 807 |
CHEST PAIN |
30 |
0.0002 |
| 808 |
ARTHROPATHY |
9 |
0.0002 |
| 809 |
FEMUR FRACTURE |
5 |
0.0002 |
| 810 |
INJECTION SITE ERYTHEMA |
20 |
0.0002 |
| 811 |
HYPONATRAEMIA |
9 |
0.0002 |
| 812 |
INJECTION SITE PAIN |
49 |
0.0002 |
| 813 |
INFECTION |
23 |
0.0002 |
| 814 |
FRACTURE |
3 |
0.0002 |
| 815 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
4 |
0.0002 |
| 816 |
GASTRIC CANCER |
4 |
0.0002 |
| 817 |
DIABETES MELLITUS |
12 |
0.0002 |
| 818 |
HEPATITIS |
4 |
0.0002 |
| 819 |
ACUTE RESPIRATORY FAILURE |
3 |
0.0002 |
| 820 |
GENERAL PHYSICAL HEALTH DETERIORATION |
18 |
0.0002 |
| 821 |
ANOREXIA |
2 |
0.0002 |
| 822 |
ANXIETY |
44 |
0.0002 |
| 823 |
MOBILITY DECREASED |
11 |
0.0002 |
| 824 |
DISABILITY |
3 |
0.0002 |
| 825 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
| 826 |
PREGNANCY |
3 |
0.0001 |
| 827 |
PRODUCT PHYSICAL ISSUE |
3 |
0.0001 |
| 828 |
ANGER |
5 |
0.0001 |
| 829 |
NEUTROPENIA |
20 |
0.0001 |
| 830 |
PNEUMONITIS |
4 |
0.0001 |
| 831 |
TREATMENT NONCOMPLIANCE |
8 |
0.0001 |
| 832 |
ABDOMINAL PAIN |
34 |
0.0001 |
| 833 |
HAEMATURIA |
5 |
0.0001 |
| 834 |
SKIN LESION |
4 |
0.0001 |
| 835 |
CHILLS |
17 |
0.0001 |
| 836 |
HAEMATOCHEZIA |
8 |
0.0001 |
| 837 |
RESPIRATORY DISTRESS |
4 |
0.0001 |
| 838 |
PERITONITIS |
3 |
0.0001 |
| 839 |
PULMONARY HYPERTENSION |
3 |
0.0001 |
| 840 |
NEOPLASM PROGRESSION |
5 |
0.0001 |
| 841 |
CARPAL TUNNEL SYNDROME |
2 |
0.0001 |
| 842 |
KNEE ARTHROPLASTY |
3 |
0.0001 |
| 843 |
INJURY |
10 |
0.0001 |
| 844 |
RENAL FAILURE ACUTE |
6 |
0.0001 |
| 845 |
ABDOMINAL PAIN UPPER |
29 |
0.0001 |
| 846 |
JOINT INJURY |
3 |
0.0001 |
| 847 |
THERAPY INTERRUPTED |
10 |
0.0001 |
| 848 |
AGGRESSION |
7 |
0.0001 |
| 849 |
PARAESTHESIA |
22 |
0.0001 |
| 850 |
HYPERHIDROSIS |
18 |
0.0001 |
| 851 |
ELECTROCARDIOGRAM QT PROLONGED |
5 |
0.0001 |
| 852 |
PRURITUS GENERALISED |
3 |
0.0001 |
| 853 |
ASTHENIA |
52 |
0.0001 |
| 854 |
INTENTIONAL PRODUCT MISUSE |
12 |
0.0001 |
| 855 |
INTENTIONAL PRODUCT USE ISSUE |
12 |
0.0001 |
| 856 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 857 |
RENAL FAILURE |
18 |
0.0001 |
| 858 |
CARDIOMYOPATHY |
2 |
0.0001 |
| 859 |
MYALGIA |
23 |
0.0001 |
| 860 |
CONTUSION |
13 |
0.0001 |
| 861 |
TOOTH DISORDER |
3 |
0.0001 |
| 862 |
PULMONARY OEDEMA |
6 |
0.0001 |
| 863 |
ORAL PAIN |
3 |
0.0001 |
| 864 |
RASH PAPULAR |
3 |
0.0001 |
| 865 |
ADVERSE DRUG REACTION |
12 |
0.0001 |
| 866 |
LOSS OF CONSCIOUSNESS |
17 |
0.0001 |
| 867 |
PANCREATITIS |
7 |
0.0001 |
| 868 |
DYSPEPSIA |
13 |
0.0001 |
| 869 |
COLITIS |
5 |
0.0001 |
| 870 |
DEPRESSION |
30 |
0.0001 |
| 871 |
GASTROINTESTINAL HAEMORRHAGE |
11 |
0.0001 |
| 872 |
VERTIGO |
8 |
0.0001 |
| 873 |
ACUTE KIDNEY INJURY |
20 |
0.0001 |
| 874 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 875 |
EMOTIONAL DISORDER |
4 |
0.0001 |
| 876 |
BASAL CELL CARCINOMA |
2 |
0.0001 |
| 877 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
7 |
0.0001 |
| 878 |
TREMOR |
21 |
0.0001 |
| 879 |
DISORIENTATION |
5 |
0.0001 |
| 880 |
ACCIDENTAL EXPOSURE TO PRODUCT |
13 |
0.0001 |
| 881 |
ABSCESS |
2 |
0.0001 |
| 882 |
DIABETIC KETOACIDOSIS |
3 |
0.0001 |
| 883 |
HIP FRACTURE |
4 |
0.0001 |
| 884 |
HYPOGLYCAEMIA |
6 |
0.0001 |
| 885 |
DEVICE BREAKAGE |
5 |
0.0001 |
| 886 |
DYSKINESIA |
5 |
0.0001 |
| 887 |
PRODUCT DOSE OMISSION |
8 |
0.0001 |
| 888 |
AGITATION |
9 |
0.0001 |
| 889 |
IMPAIRED HEALING |
4 |
0.0001 |
| 890 |
LUNG NEOPLASM MALIGNANT |
5 |
0.0001 |
| 891 |
SEIZURE |
14 |
0.0001 |
| 892 |
OFF LABEL USE |
106 |
0.0001 |
| 893 |
AGEUSIA |
3 |
0.0001 |
| 894 |
SKIN DISORDER |
4 |
0.0001 |
| 895 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 896 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
| 897 |
DRUG EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 898 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
3 |
0.0001 |
| 899 |
HYPOACUSIS |
5 |
0.0001 |
| 900 |
SUICIDE ATTEMPT |
7 |
0.0001 |
| 901 |
NERVOUSNESS |
6 |
0.0001 |
| 902 |
HAEMORRHAGE |
12 |
0.0001 |
| 903 |
JOINT STIFFNESS |
3 |
0.0001 |
| 904 |
SOMNOLENCE |
23 |
0.0001 |
| 905 |
MUSCULOSKELETAL STIFFNESS |
10 |
0.0001 |
| 906 |
BREAST CANCER FEMALE |
3 |
0.0001 |
| 907 |
DISTURBANCE IN ATTENTION |
6 |
0.0001 |
| 908 |
OVERDOSE |
24 |
0.0001 |
| 909 |
RESPIRATORY FAILURE |
8 |
0.0001 |
| 910 |
DYSURIA |
4 |
0.0001 |
| 911 |
ABNORMAL DREAMS |
3 |
0.0001 |
| 912 |
FEELING COLD |
3 |
0.0001 |
| 913 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 914 |
DRUG INTERACTION |
17 |
0.0001 |
| 915 |
DYSARTHRIA |
4 |
0.0001 |
| 916 |
HALLUCINATION |
8 |
0.0001 |
| 917 |
ARRHYTHMIA |
5 |
0.0001 |
| 918 |
CHRONIC KIDNEY DISEASE |
8 |
0.0001 |
| 919 |
INCORRECT DOSE ADMINISTERED |
24 |
0.0001 |
| 920 |
ANGINA PECTORIS |
3 |
0.0001 |
| 921 |
BLOOD GLUCOSE DECREASED |
5 |
0.0001 |
| 922 |
BALANCE DISORDER |
9 |
0.0001 |
| 923 |
DRUG INTOLERANCE |
10 |
0.0001 |
| 924 |
NEEDLE ISSUE |
3 |
0.0001 |
| 925 |
DYSSTASIA |
3 |
0.0001 |
| 926 |
MEMORY IMPAIRMENT |
14 |
0.0001 |
| 927 |
ALOPECIA |
20 |
0.0001 |
| 928 |
APHASIA |
3 |
0.0001 |
| 929 |
ILL-DEFINED DISORDER |
6 |
0.0001 |
| 930 |
BONE MARROW FAILURE |
2 |
0.0001 |
| 931 |
SUICIDAL IDEATION |
9 |
0.0001 |
| 932 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 933 |
BREAST CANCER |
9 |
0.0001 |
| 934 |
NERVOUS SYSTEM DISORDER |
3 |
0.0001 |
| 935 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 936 |
BRADYCARDIA |
5 |
0.0001 |
| 937 |
DISEASE PROGRESSION |
11 |
0.0001 |
| 938 |
AMNESIA |
6 |
0.0001 |
| 939 |
MENTAL DISORDER |
4 |
0.0001 |
| 940 |
PSORIASIS |
12 |
0.0001 |
| 941 |
MYOCARDIAL INFARCTION |
16 |
0.0001 |
| 942 |
OSTEONECROSIS |
3 |
0.0001 |
| 943 |
APPLICATION SITE PAIN |
2 |
0.0001 |
| 944 |
ANGIOEDEMA |
4 |
0.0001 |
| 945 |
VISUAL ACUITY REDUCED |
3 |
0.0001 |
| 946 |
NEOPLASM MALIGNANT |
6 |
0.0001 |
| 947 |
TRANSIENT ISCHAEMIC ATTACK |
3 |
0.0001 |
| 948 |
APPLICATION SITE PRURITUS |
2 |
0.0001 |
| 949 |
INJECTION SITE REACTION |
6 |
0.0001 |
| 950 |
LETHARGY |
5 |
0.0001 |
| 951 |
COLORECTAL CANCER |
4 |
0.0001 |
| 952 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
4 |
0.0001 |
| 953 |
DRUG EFFECT INCOMPLETE |
3 |
0.0001 |
| 954 |
ABASIA |
2 |
0.0001 |
| 955 |
EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 956 |
SYNCOPE |
8 |
0.0001 |
| 957 |
THERAPY CESSATION |
4 |
0.0001 |
| 958 |
APPLICATION SITE ERYTHEMA |
2 |
0.0001 |
| 959 |
INJECTION SITE HAEMORRHAGE |
6 |
0.0001 |
| 960 |
THROMBOSIS |
6 |
0.0001 |
| 961 |
EMOTIONAL DISTRESS |
9 |
0.0001 |
| 962 |
PULMONARY EMBOLISM |
7 |
0.0001 |
| 963 |
MULTIPLE SCLEROSIS RELAPSE |
5 |
0.0001 |
| 964 |
COMPLETED SUICIDE |
6 |
0.0001 |
| 965 |
ROAD TRAFFIC ACCIDENT |
3 |
0.0001 |
| 966 |
DEVICE MALFUNCTION |
5 |
0.0001 |
| 967 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
5 |
0.0001 |
| 968 |
PRODUCT STORAGE ERROR |
6 |
0.0001 |
| 969 |
BONE PAIN |
4 |
0.0001 |
| 970 |
ACUTE MYOCARDIAL INFARCTION |
2 |
0.0001 |
| 971 |
COLITIS ULCERATIVE |
3 |
0.0001 |
| 972 |
DEVICE ISSUE |
6 |
0.0001 |
| 973 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
0.0001 |
| 974 |
UNEVALUABLE EVENT |
5 |
0.0001 |
| 975 |
LOWER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 976 |
BONE DENSITY DECREASED |
2 |
0.0001 |
| 977 |
CEREBROVASCULAR ACCIDENT |
10 |
0.0001 |
| 978 |
SPEECH DISORDER |
3 |
0.0001 |
| 979 |
DRUG EFFECT DECREASED |
3 |
0.0001 |
| 980 |
CONFUSIONAL STATE |
9 |
0.0001 |
| 981 |
ADVERSE EVENT |
5 |
0.0001 |
| 982 |
FLATULENCE |
3 |
0.0001 |
| 983 |
ACNE |
4 |
0.0001 |
| 984 |
CARDIAC ARREST |
4 |
0.0000 |
| 985 |
DRUG DOSE OMISSION |
8 |
0.0000 |
| 986 |
DRUG ABUSE |
4 |
0.0000 |
| 987 |
BLOOD GLUCOSE INCREASED |
9 |
0.0000 |
| 988 |
INTENTIONAL OVERDOSE |
3 |
0.0000 |
| 989 |
DEATH |
40 |
0.0000 |
| 990 |
SKIN BURNING SENSATION |
3 |
0.0000 |
| 991 |
HOSPITALISATION |
6 |
0.0000 |